Medicare&Aging 071421
As Congress Wrestles With Plans to Expand Medicare, Becerra Says Any One Will Do
Julie Rovner
In an interview for KHN’s “What the Health?” podcast, HHS Secretary Xavier Becerra says the administration is eager for Congress to make changes to Medicare that will provide more benefits and make more older adults eligible for the program. He also said a priority will be making permanent the enhanced premium subsidies for Affordable Care Act marketplace plans.
Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
Michael McAuliff
The pharmaceutical industry argues that large profits are needed to fund extensive research and innovation. But Democrats on the House Oversight and Reform Committee, seeking to bolster their effort to let Medicare negotiate drug prices, say major drug companies plow more of their billions in earnings back into propping up their stock and enriching executives and shareholders.
Paying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?
Judith Graham
Aduhelm, approved by the Food and Drug Administration last month despite questions about its efficacy, could be prescribed to at least 1 million patients a year, for a price tag of about $56 billion. Experts suggest there might be better ways to spend that money.
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
Elisabeth Rosenthal
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug
Judith Graham
The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.
Hospital Prices Must Now Be Transparent. For Many Consumers, They’re Still Anyone’s Guess.
Julie Appleby
A Trump administration rule mandating that hospitals disclose true prices on their websites took effect this year. But compliance is spotty and even when the data is public, it’s hard to find and understand.
The Hard Realities of a ‘No Jab, No Job’ Mandate for Health Care Workers
Christine Spolar
Despite a hearts-and-minds campaign and millions spent in incentives, managers struggle to get staffs vaccinated against covid. Some workers have threatened to quit over the pressure to get a shot, which employers can’t afford.
Unvaccinated, Homebound and Now Hospitalized With Covid in New York City
Fred Mogul
Across the country, doctors report that those hospitalized with covid now are largely unvaccinated. New York City lags the rest of the nation in vaccinating people 65 and older, and its efforts to reach the homebound and disabled have been late in coming and disorganized.
Device Makers Have Funneled Billions to Orthopedic Surgeons Who Use Their Products
Fred Schulte and Elizabeth Lucas
Federal officials say that some of the money changing hands has corrupted doctors and endangered patients.
Teen Volunteers Get a Foot in the Door for Nursing Home Careers
Michelle Andrews
A group of New York senior living facilities offer teens from 10 underserved schools the chance to volunteer and get free training for entry-level health jobs, career coaching and assistance on college prep.
Violent Colorado Arrest Puts Spotlight on How Police Treat Disabled People
Leigh Paterson
Criminal charges filed against two officers who injured a Colorado woman with dementia don’t address the fact that police often lack the skills to effectively deal with suspects with mental disabilities.
Desperate for Home Care, Seniors Often Wait Months With Workers in Short Supply
Phil Galewitz
The covid pandemic and President Joe Biden's agenda — a planned $400 billion infusion of support — have focused national attention on the need to expand home- and community-based long-term care services designed to keep people out of nursing homes. But the need far outpaces the staffing.
Calming Computer Jitters: Help for Seniors Who Aren’t Tech-Savvy
Judith Graham
Millions of older adults want to be comfortable going online and using digital tools to enhance their lives. But many need help. A number of groups around the country offer assistance.
Biden Quietly Transforms Medicaid Safety Net
Noam N. Levey and Phil Galewitz
In a sharp shift from Trump-era policies, President Joe Biden looks at expanding Medicaid eligibility to new mothers, inmates and undocumented immigrants and adding services such as food and housing.
KHN’s ‘What the Health?’: Becerra Urges Congress to Expand Medicare, Address Rx Prices
Health and Human Services Secretary Xavier Becerra is the special guest for this bonus episode of KHN’s “What the Health?” podcast. He and host Julie Rovner discuss a breadth of topics the secretary oversees, including covid-19, prescription drug prices, Medicare, Medicaid and the Affordable Care Act.
KHN’s ‘What the Health?’: Un-Trumping the ACA
The Biden administration is moving to undo many of the changes the Trump administration made to the enrollment process for the Affordable Care Act to encourage more people to sign up for health insurance. Meanwhile, Congress is opening investigations into the controversial approval by the Food and Drug Administration of an expensive drug that might (or might not) slow the progression of Alzheimer’s disease. Joanne Kenen of Politico, Kimberly Leonard of Insider and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Marshall Allen of ProPublica about his new book, “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”
KHN’s ‘What the Health?’: How to Expand Health Coverage
Democrats in Congress and the states are devising strategies to expand health coverage — through the Affordable Care Act, Medicare, Medicaid and a “public option.” But progress remains halting, at best. Meanwhile, lawmakers in Washington may have to agree on how to control prescription drug prices if they wish to finance their coverage initiatives. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Shefali Luthra of The 19th join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Michelle Andrews, who reported and wrote last month’s KHN-NPR “Bill of the Month” episode about a very expensive sleep study.
KHN’s ‘What the Health?’: The ACA Lives
In a surprisingly strong 7-2 decision, the Supreme Court turned back the latest constitutional challenge to the Affordable Care Act, likely heralding the end of GOP efforts to strike the law in its entirety through court action. Meanwhile, Democratic lawmakers are looking for ways to expand health benefits. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Andy Slavitt, who recently stepped down from the Biden administration’s covid response team, about his new book on the pandemic.
KHN’s ‘What the Health?’: Our 200th Episode!
The federal approval of a controversial drug to treat Alzheimer’s disease has reignited the debate over drug prices and the way the Food and Drug Administration makes decisions. Meanwhile, President Joe Biden seeks to gain goodwill overseas as he announces the U.S. will provide 500 million doses of covid vaccine to international health efforts. Sarah Karlin-Smith of the Pink Sheet, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Chiquita Brooks-LaSure, the new administrator of the Centers for Medicare & Medicaid Services. And to mark the podcast’s 200th episode, the panelists discuss what has surprised them most and least over the past four years.
Discretamente, Biden está transformando la red de seguridad de Medicaid
Noam N. Levey and Phil Galewitz
Los esfuerzos de Biden, que han sido eclipsados en gran medida por otras iniciativas económicas y de salud, representan un cambio abrupto en contra de todo lo que la administración Trump hizo para reducir el programa.